Coupang, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Coupang, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC GlobeNewswire January 14, 2026 NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, […]

Berkeley Earth: 2025 Was the Third Warmest Year on Record, Extending an Unprecedented Run of Global Heat

Berkeley Earth’s 2025 Annual Temperature Report finds that 2025 was the third warmest year on record globally, with average temperatures reaching 1.44 ± 0.09°C above the pre-industrial baseline and approximately 770 million people experiencing locally record-warm conditions. The findings extend an unprecedented run of global heat and highlight a pronounced warming spike from 2023-2025 that

Discover Asia’s Winter Magic: Agoda Recommends Snowy Escapes for 2026

As the 2026 winter season unfolds, digital travel platform Agoda spotlights Asia’s top snow destinations, offering travelers unparalleled experiences in some of the region’s most captivating winter wonderlands. The allure of snow-filled landscapes continues to captivate travelers, with many eager to explore the unique cultural and natural offerings of Asia’s premier snowy retreats. With a

BBWI LAWSUIT FILED: Bath & Body Works, Inc. Hit with Securities Fraud Class Action Over Failed Sales Strategy – Contact BFA Law before March 13 Deadline

(NYSE:BBWI), NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE:BBWI) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the

BBWI LAWSUIT FILED: Bath & Body Works, Inc. Hit with Securities Fraud Class Action Over Failed Sales Strategy – Contact BFA Law before March 13 Deadline

BBWI LAWSUIT FILED: Bath & Body Works, Inc. Hit with Securities Fraud Class Action Over Failed Sales Strategy – Contact BFA Law before March 13 Deadline GlobeNewswire January 14, 2026 NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been

Avestar Capital Launches Singapore Office

US-Based Multi-Family Office Strengthens Global Footprint to Serve Asia’s Ultra-Wealthy Families Avestar Capital, a leading U.S.-based multi-family office, today announced the official launch of its Singapore operations under AVESTAR SINGAPORE PLC PTE. LTD., marking a major milestone in its global expansion strategy. The new office will serve as Avestar’s Asia-Pacific hub, extending its founder-led approach

AWOL Vision Announces NFL Quarterback Kirk Cousins as Brand Ambassador Following CES 2026 Debut

AWOL Vision, a global leader in next-generation audiovisual technology, announced NFL quarterback Kirk Cousins as its Brand Ambassador, representing both AWOL Vision and its premium sub-brand, Valerion. The partnership debuts at CES 2026 alongside the launch of Aetherion series, AWOL Vision’s latest ultra-short-throw (UST) projector lineup. Known for his accuracy, preparation, and leadership on the

Conscientia Health Honored as “Best Psychiatrist” by Patient Ratings on Google Reviews

Conscientia Health is proud to announce that it has been recognized as “Best Psychiatrist” practice based on patient ratings via Google Reviews. This award reflects the trust and gratitude of the Red Bank community and affirms Conscientia Health’s ongoing commitment to delivering compassionate, evidence?based mental health care. Conscientia Health Honored as “Best Psychiatrist” by Patient

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

(TSX:BCT),(NASDAQ:BCTX),(NASDAQ:BCTXW),(NASDAQ:BCTXZ),(NASDAQ:BCTXL), PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of a best-efforts public offering of 5,366,726 units. Each unit consists of one common share

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

BriaCell Therapeutics Announces Pricing of $30 million Public Offering GlobeNewswire January 14, 2026 PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of a best-efforts

Scroll to Top